Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...
1 Department of Rehabilitation Sciences and Physical Therapy, Faculty of Medicine ... of the lumbar multifidus muscle in patients with chronic low back pain. Methods—Each of 59 nine patients was ...